Skip to content
OpenCapital
Get started

Solventum SOLV Retirement and nonpension postretirement benefit obligations

Retirement and nonpension postretirement benefit obligations at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.03B+17.8%
3M logo
3MMMM
$1.59B-12.1%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——
Abbott logo
AbbottABT
——
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$2.0B-3.0%
Gross profit$1.1B-1.5%
Operating income$81.0M-46.7%
Net income$13.0M-90.5%
EPS (diluted)$0.07-91.0%

Balance sheet

See full
Cash & equivalents$561.0M+5.1%
Total debt$5.8B-26.8%
Total equity$5.0B+52.3%
Total assets$14.1B-3.0%

Cash flow

See full
Operating cash flow-$189.0M-752%
CapEx$84.0M-22.9%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$13.06B-13.9%
Enterprise value$18.29B-19.4%
P/E9.1×-30.9×
P/S1.6×-0.2×

Profitability

See full
Gross margin53.7%-0.9pp
Operating margin25.5%+15.8pp
Net margin17.3%+12.8pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34.8%+24.1pp
Debt / equity1.2×-1.3×
Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's retirement and nonpension postretirement benefit obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solventum's retirement and nonpension postretirement benefit obligations?
Solventum (SOLV) reported retirement and nonpension postretirement benefit obligations of $360M in Q1 2026.
How has Solventum's retirement and nonpension postretirement benefit obligations changed year-over-year?
Solventum's retirement and nonpension postretirement benefit obligations increased by 7.8% year-over-year, from $334M to $360M.
What is the long-term trend for Solventum's retirement and nonpension postretirement benefit obligations?
Over 2 years (2023 to 2025), Solventum's retirement and nonpension postretirement benefit obligations has grown at a 47.9% compound annual growth rate (CAGR), from $166M to $363M.